[Skip to Content]
[Skip to Content Landing]
Views 2,064
Citations 0
Editorial
August 31, 2017

Medication and Cognitive Behavioral Therapy for Pediatric Anxiety DisordersNo Need for Anxiety in Treating Anxiety

Author Affiliations
  • 1David Geffen School of Medicine, Semel Institute of Neuroscience & Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles
  • 2Stony Brook University School of Medicine, Department of Psychiatry & Pediatrics, State University of New York at Stony Brook
JAMA Pediatr. Published online August 31, 2017. doi:10.1001/jamapediatrics.2017.3017

Anxiety disorders are among the most prevalent pediatric behavioral health conditions, affecting roughly 32% of youths prior to adulthood, and associated with impaired functioning that can continue into adulthood and increase in severity.1,2 In this issue of JAMA Pediatrics, Wang et al3 report an updated meta-analysis evaluating the comparative efficacy of cognitive behavioral therapy (CBT) and pharmacotherapy for pediatric anxiety disorders. Results supported the efficacy of CBT, selective serotonin reuptake inhibitors (SSRIs), and their combination; limited support was provided for serotonin-norepinephrine reuptake inhibitors (SNRIs). We briefly review the evidence followed by implementation issues.

First Page Preview View Large
First page PDF preview
First page PDF preview
×